CORDIS
EU research results

CORDIS

English EN

European NoVel Imaging Systems for ION therapy

Objective

Following the pioneering experiences which lasted several decades, particle therapy has become a recognized way of curing cancer. 2 new European dual-ion facilities (Heidelberg, Pavia) will soon become operational, followed by several others which are today at different stages of planning and construction. Hadron therapy faces the challenge of improving treatment outcomes with tools able to provide on-line a 4 dimensional feedback of the irradiation to enhance the dose conformation to the cancer volume and improve the treatment of moving organs. ENVISION is set up by 15 leading European research organisations, and 1 leading industrial partner IBA , to respond to these challenges. CERN is project coordinator and the majority of the key European experts in this field are involved, as well as the Hadron Research Facilities (Heidelberg, Pavia) who will immediately benefit from the developments foreseen in this project. A valorisation committee with members of the industrial partners has been established to maximally exploit the results. ENVISION tackles the problems of on-line Dose Monitoring and of performing accurate Quality Assurance tests by developing novel imaging modalities related to dose deposition and allow assessing the treated volume and deriving reliable indicators of the delivered dose. It concentrates on the detection of nuclear reaction products produced by the interaction of the beam with atomic nuclei of the tissue (positron emitting nuclides for ibPET, photons or light charged particles for ibSPAT). The methods are applicable to all therapy relevant ion species. The application of TOF techniques with superior time resolution to beam delivery integrated double head ibPET scanners has the potential for improving ibPET image quality. Furthermore, the real-time observation of the dose delivery process will become feasible for the 1st time, substantially reducing intervention times in case of treatment mistakes or incidents.

Coordinator

EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH

Address

Route De Meyrin Cern
1211 Geneva 23

Switzerland

Activity type

Research Organisations

EU Contribution

€ 1 013 265,25

Administrative Contact

Manjit Dosanjh (Prof.)

Participants (15)

Sort alphabetically

Sort by EU Contribution

Expand all

TECHNISCHE UNIVERSITAET DRESDEN

Germany

EU Contribution

€ 675 556

MEDIZINISCHE UNIVERSITAET WIEN

Austria

EU Contribution

€ 229 120

UNIVERSITE LYON 1 CLAUDE BERNARD

France

EU Contribution

€ 431 721,60

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 403 940

ION BEAM APPLICATIONS SA

Belgium

EU Contribution

€ 483 232

ISTITUTO NAZIONALE DI FISICA NUCLEARE

Italy

EU Contribution

€ 387 540

FONDAZIONE PER ADROTERAPIA ONCOLOGICA - TERA

Italy

EU Contribution

€ 262 060

Heidelberg University Hospital

Germany

EU Contribution

€ 326 048,80

GSI HELMHOLTZZENTRUM FUER SCHWERIONENFORSCHUNG GMBH

Germany

EU Contribution

€ 175 675,75

STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC

Netherlands

EU Contribution

€ 156 494,80

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

France

EU Contribution

€ 532 754,40

AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

Spain

EU Contribution

€ 488 740,48

UNIVERSITEIT GENT

Belgium

EU Contribution

€ 149 615,73

POLITECNICO DI MILANO

Italy

EU Contribution

€ 179 487,95

UNIVERSIDAD DE CASTILLA - LA MANCHA

Spain

EU Contribution

€ 101 207,52

Project information

Grant agreement ID: 241851

Status

Closed project

  • Start date

    1 February 2010

  • End date

    31 July 2014

Funded under:

FP7-HEALTH

  • Overall budget:

    € 9 305 864,89

  • EU contribution

    € 5 996 460,28

Coordinated by:

EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH

Switzerland